40. 高安動脈炎 [臨床試験数:22,薬物数:46(DrugBank:20),標的遺伝子数:22,標的パスウェイ数:111

Searched query = "Takayasu arteritis", "Aortitis syndrome", "Pulseless disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04564001September 202021/9/2020Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu ArteritisMulticentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu ArteritisTakayasu ArteritisDrug: Infliximab;Drug: TocilizumabAssistance Publique - Hôpitaux de ParisNULLNot yet recruiting18 YearsN/AAll50Phase 2NULL
2EUCTR2018-003753-13-FR19/03/201913/12/2018INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritisMulticentre, randomized, prospective trial comparing the efficacy and safety of Infliximab to tocilizumab in refractory or relapsing Takayasu arteritis Patients with refractory or relapsing Takayasu Arteritis desease;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]Trade Name: RoActemra 20mg/ml
Product Name: Tocilizumab
INN or Proposed INN: Tocilizumab
Other descriptive name: TOCILIZUMAB
Product Name: Infliximab
INN or Proposed INN: INFLIXIMAB
ASSISTANCE PUBLIQUE - HOPITAUX DE PARISNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
50Phase 3France
3NCT03192878March 1, 20179/5/2017Infliximab Biosimilar in Takayasu's ArteritisA Prospective Observational Study of Infliximab Biosimilar in the Treatment of Takayasu's Arteritis Resistant to Corticosteroids and Conventional Immune-suppressive TreatmentsTakayasu ArteritisDrug: InfliximabOspedale San RaffaeleNULLRecruiting18 YearsN/AAll30N/AItaly